Tabas lab publishes study on mechanisms of HCC development in NASH in the Journal of Hepatology, in collaboration with CU-DLDRC members Utpal Pajvani, Betsy Verna, Robert Schwabe, Helen Remotti. Congrats to first author Xiaobo and to Ira! https://t.co/Xk7lROo5mY
Tabas Lab at Columbia University has an open postdoc position to study: (1) macrophage metabolic pathways (immunometabolism) that promote atherosclerosis progression (2) human genetic risk factors for CAD and (3) systemic insulin resistance. Info below 👇
https://t.co/dOFUgP0WwL
Ira Tabas, @xiaobowang & fellow researchers @ColumbiaPS show that hepatocyte cholesterol contributes to fibrotic #NASH by increasing TAZ.
https://t.co/W6gfBxeENk
Space still available for tonight's "#COVID19 & the Liver - Case Studies & Updates" webinar, scheduled for 5 pm ET.
@orenkfix & @elizabeth_verna are presenting.
Learn more & register: https://t.co/n09TWRo8Kq
Submit Qs ahead of time: https://t.co/uaJ3LEO6GW #LiverTwitter